Virtual or in person, we participate in many conferences as speakers, exhibitors or attendees.
We regularly attend conferences organised by the Royal Society of Chemistry, The International Society for the Study of Xenobiotics (ISSX), the Drug Metabolism Discussion Group (DMDG) the Society of Chemical Industry (SCI), the Pharmaceutical and Bioscience Society (PBSS) and The Boston Society.
Let us know if you’d like to connect at any of the meetings we’re attending this year.
Frank Scheffler will be presenting a poster at the International Isotope Society’s 25th IIS-CED Workshop taking place on May 5th-6th 2022 in Bad Soden. The meeting focusses on the synthesis and application of isotopes and isotopically labelled compounds.
Julia Shanu-Wilson and Vincent Poon will be giving a talk at the 5th RSC / DMDG / DMG New Perspectives in DMPK meeting taking place 22-23 February 2022. The title of their double act talk is “Development of PolyCYPs as part of a One-Stop Metabolite Shop Strategy.”
Hypha will be participating in the DMDG’s 2nd European Biotransformation Workshop being held 24-25 November 2021. The purpose of this workshop is to provide a platform for biotransformation scientists to discuss topics of interest to them and the biotransformation community at large.
Hypha are proud to sponsor the DMDG Open Meeting 2021 being held 18-20 October 2021 and which will be celebrating 50 years of the DMDG. Julia Shanu-Wilson will be available for discussions at Hypha’s virtual exhibit.
Julia Shanu-Wilson will be giving a talk at the Boston PBSS workshop on Radio-labeled Mass Balance and Metabolite Profiling Studies: Fundamentals, Best Practices, Regulatory Requirements, Applications and Case Studies.
Stay up to date with the latest news from Hypha Discovery
Sign up for our Newsletter to receive interesting updates and scientific case studies about Hypha’s metabolite generation capabilities and lead optimization solutions
Ready to begin? Our scientists are available to talk through your requirements
Hypha Discovery is a UK-based CRO supporting pharmaceutical and agrochemical companies worldwide through the production of metabolites and new derivatives of drugs and agrochemicals in discovery and development.